1. Search Result
Search Result
Results for "

NEDD4

" in MedChemExpress (MCE) Product Catalog:

15

Inhibitors & Agonists

1

Natural
Products

5

Recombinant Proteins

2

Antibodies

6

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-162809

    Ras Cancer
    XMU-MP-9 is a bifunctional compound that binds to the C2 domain of Nedd4-1 and the allosteric site of K-Ras. XMU-MP-9 enhances the interaction between Nedd4-1 and K-Ras, induces conformational changes in the Nedd4-1/K-Ras complex, promotes the ubiquitination and degradation of multiple K-Ras mutants, and inhibits the proliferation of cells carrying K-Ras mutants. XMU-MP-9 can be used for the study of colon, lung and pancreatic cancer .
    XMU-MP-9
  • HY-N10159

    Others Cancer
    1-Benzyl-I3C is a NEDD4-1 inhibitor with significant anticancer activity. 1-Benzyl-I3C can directly inhibit the ubiquitination activity of NEDD4-1 with an IC50 of 12.3μM, which is significantly better than its precursor compound I3C of 284μM. 1-Benzyl-I3C and its analogs showed good effects in inhibiting the proliferation of human melanoma cells, which is roughly related to their potency as NEDD4-1 enzyme inhibitors. By combining in vitro ubiquitination experiments and thermal stability analysis, 1-Benzyl-I3C was shown to be able to bind to the catalytic HECT domain of NEDD4-1 .
    1-Benzyl-I3C
  • HY-110174

    α-synuclein Neurological Disease
    NAB2 is a neuroprotectant that targets the small GTPase Rab1a. NAB2 selectively binds to the GDP-bound form of Rab1a and protects multiple cell types from α-synuclein toxicity by increasing Rab1a expression. Rab1a regulates ER-to-Golgi trafficking and mediates endosomal trafficking events of the E3 ubiquitin ligase Rsp5/Nedd4. NAB2 stimulates ubiquitination of related proteins in a Nedd4-dependent manner and rescues α-synuclein-associated trafficking defects associated with early-onset Parkinson's disease .
    NAB2
  • HY-RS23685

    Small Interfering RNA (siRNA) Others

    Nedd4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nedd4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nedd4 Rat Pre-designed siRNA Set A
    Nedd4 Rat Pre-designed siRNA Set A
  • HY-RS17232

    Small Interfering RNA (siRNA) Others

    Nedd4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nedd4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nedd4 Mouse Pre-designed siRNA Set A
    Nedd4 Mouse Pre-designed siRNA Set A
  • HY-RS09179

    Small Interfering RNA (siRNA) Others

    NEDD4 Human Pre-designed siRNA Set A contains three designed siRNAs for NEDD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    NEDD4 Human Pre-designed siRNA Set A
    NEDD4 Human Pre-designed siRNA Set A
  • HY-174375

    Others Cancer
    NEDD4-IN-1 (Compound 32) is a potent inhibitor of NEDD4 (IC50 = 0.12 μM). NEDD4-IN-1 shows significant and comparable antiproliferative activity in H292 cell line. NEDD4-IN-1 demonstrates high plasma protein binding and medium-to-high in vitro clearance in both human and mouse models. NEDD4-IN-1 shows superior stability in mouse plasma. NEDD4-IN-1 has excellent potency, selectivity, and favourable in vitro ADME properties. NEDD4-IN-1 exhibits a systemic plasma clearance exceeding the hepatic blood flow in mouse model. NEDD4-IN-1 can be studied in anticancer research .
    NEDD4-IN-1
  • HY-RS17116

    Small Interfering RNA (siRNA) Others

    Nedd4l Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nedd4l gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nedd4l Mouse Pre-designed siRNA Set A
    Nedd4l Mouse Pre-designed siRNA Set A
  • HY-RS09180

    Small Interfering RNA (siRNA) Others

    NEDD4L Human Pre-designed siRNA Set A contains three designed siRNAs for NEDD4L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    NEDD4L Human Pre-designed siRNA Set A
    NEDD4L Human Pre-designed siRNA Set A
  • HY-RS23561

    Small Interfering RNA (siRNA) Others

    Nedd4l Rat Pre-designed siRNA Set A contains three designed siRNAs for Nedd4l gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Nedd4l Rat Pre-designed siRNA Set A
    Nedd4l Rat Pre-designed siRNA Set A
  • HY-110204
    Heclin
    2 Publications Verification

    E1/E2/E3 Enzyme Akt MyD88 Others
    Heclin is a HECT E3 ubiquitin ligases inhibitor. Heclin inhibits Smurf2, Nedd4, WWP1 (IC50 values are 6.8, 6.3, 6.9 μM) and can be used for the research of gastric cancer .
    Heclin
  • HY-153178

    E1/E2/E3 Enzyme Others
    HECT E3-IN-1 (compound 3) is a HECT E3 ligase inhibitor. HECT E3-IN-1 (compound 3) disrupts Ub binding to the noncovalent Ub-binding site of Nedd4-1 .
    HECT E3-IN-1
  • HY-122046

    Endogenous Metabolite Infection
    Amb123203 is an antiviral compound with the activity of inhibiting viral budding. Amb123203 exerts its effect by blocking the interaction between mVP40 and Nedd4 proteins. Amb123203 has a significant inhibitory effect on the budding of VP40 virus-like particles (VLPs) of Marburg (MARV) and Ebola viruses. Amb123203 can effectively target RNA viruses that rely on the PPxY L domain for efficient budding, showing broad-spectrum antiviral activity. The discovery of Amb123203 provides an important basis for the development of new broad-spectrum antiviral compounds .
    Amb123203
  • HY-174415

    PROTACs EGFR Akt ERK Cancer
    ZSH-2117 is a covalent and selective EGFR PROTAC degrader with a DC50 of 45 nM in Ba/F3-EGFR L858R/T790M/C797S cells. ZSH-2117 significantly inhibits cell proliferation and reduces the downstream EGFR signaling proteins level of AKT and ERK. ZSH-2117 effectively inhibits tumor growth in Ba/F3-EGFR L858R/T790M/C797S xenograft mice model . Pink: EGFR ligand (HY-175162); Blue: NEDD4 ligase ligand (HY-175159); Black: linker
    ZSH-2117
  • HY-134417
    NSC2805
    1 Publications Verification

    E1/E2/E3 Enzyme Cancer
    NSC2805 is a WWP2 ubiquitin ligase inhibitor that can significant inhibit WWP2 activity with an IC50 of 0.38 μM. NSC2805 can be used for the research of cancer .
    NSC2805

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: